SCHEMBL23611312

SCHEMBL23611312

CC(C)Oc1ccc(-c2ncc(CNc3cc(-c4cn[nH]c4)nc(C(F)(F)F)c3)cn2)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ MAPT P10636 7/20 0.37
▸ TP53 P04637 6/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ ROCK2 O75116 2/20 0.36
▸ TRPV3 Q8NET8 1/20 0.35
▸ PTGS2 P35354 3/20 0.34
▸ PTGS1 P23219 2/20 0.34
▸ KCNQ3 O43525 1/20 0.34
▸ KCNQ2 O43526 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ S1PR1 P21453 1/20 0.33
▸ RET P07949 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30060466 1.00 CYP2C9 (0.39) CYP2C9CYP2C19MAPTTP53SMN1; SMN2
SCHEMBL23611320 0.91 CYP2C19 (0.49) CYP2C9CYP2C19MAPTTP53SMN1; SMN2
SCHEMBL30060473 0.91 CYP2C19 (0.49) CYP2C9CYP2C19MAPTTP53SMN1; SMN2
SCHEMBL30060464 0.85 MAPT (0.38) CYP2C9MAPTTP53SMN1; SMN2ROCK2
SCHEMBL23611372 0.85 MAPT (0.38) CYP2C9MAPTTP53SMN1; SMN2ROCK2
SCHEMBL30060454 0.82 CYP2C19 (0.48) CYP2C9CYP2C19MAPTTP53SMN1; SMN2
SCHEMBL23611448 0.82 CLK1 (0.37) MAPTTP53SMN1; SMN2ROCK2KDM4E
SCHEMBL30060447 0.82 CLK1 (0.37) MAPTTP53SMN1; SMN2ROCK2KDM4E
SCHEMBL23611347 0.81 VNN1 (0.35) MAPTTP53SMN1; SMN2ROCK2TRPV3
SCHEMBL30062297 0.81 VNN1 (0.35) MAPTTP53SMN1; SMN2ROCK2TRPV3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085057-A1 NOVEL PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
WO-2021136805-A1 NOVEL PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-07-08 — — WO disclosed
Send feedback